Loading insider details...
Beta
Latest Form 4 (Jul 18, 2026): Grant/Award of 85,130 ADMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 18, 2026 | ADMA BIOLOGICS, INC. (ADMA) | Grant/Award | 85,130 | n/a |
| Oct 7, 2024 | OptiNose, Inc. (OPTN) | Grant/Award | 150,000 | n/a |
| Aug 28, 2024 | Verrica Pharmaceuticals Inc. (VRCA) | Sale | 21,820 | $58.0K |
| Mar 19, 2024 | Verrica Pharmaceuticals Inc. (VRCA) | Grant/Award | 40,000 | n/a |
| Nov 16, 2023 | Verrica Pharmaceuticals Inc. (VRCA) | Sale | 18,452 | $54.1K |
| Aug 28, 2023 | Verrica Pharmaceuticals Inc. (VRCA) | Grant/Award | 62,500 | n/a |
| Mar 3, 2023 | Verrica Pharmaceuticals Inc. (VRCA) | Grant/Award | 85,000 | n/a |
| Feb 25, 2022 | Verrica Pharmaceuticals Inc. (VRCA) | Grant/Award | 75,000 | n/a |
| Jul 20, 2021 | Verrica Pharmaceuticals Inc. (VRCA) | Grant/Award | 125,000 | n/a |